The following pages link to Sylvie Chevret (Q440206):
Displaying 10 items.
- Maximum-relevance weighted likelihood estimator: application to the continual reassessment method (Q440207) (← links)
- Modeling time‐varying exposure using inverse probability of treatment weights (Q4634695) (← links)
- Estimating Regression Parameters and Degree of Dependence for Multivariate Failure Time Data (Q4668310) (← links)
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210) (← links)
- A Note on Including Time-dependent Covariate in Regression Model for Competing Risks Data (Q5122774) (← links)
- Multiobjective semisupervised learning with a right‐censored endpoint adapted to the multiple imputation framework (Q6068873) (← links)
- DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses (Q6068878) (← links)
- Clustering with missing and left‐censored data: A simulation study comparing multiple‐imputation‐based procedures (Q6071305) (← links)
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs (Q6618333) (← links)
- Surv-CRM-12: a Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression (Q6629418) (← links)
